Century Therapeutics, Inc. (IPSC)
NASDAQ · Healthcare
Century Therapeutics, Inc. Revenue 2022–2025
Century Therapeutics, Inc. annual/quarterly revenue history and growth rate from 2022 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Century Therapeutics, Inc. revenue for the quarter ending March 31, 2025 was 109.2 M, a 12667.72% increase year-over-year.
- Century Therapeutics, Inc. revenue for the twelve months ending March 31, 2025 was 111.6 M, a 2562.40% increase year-over-year.
- Century Therapeutics, Inc. annual revenue for 2025 was 109.2 M, a 1556.76% increase from 2024.
- Century Therapeutics, Inc. annual revenue for 2024 was 6.6 M, a 194.81% increase from 2023.
- Century Therapeutics, Inc. annual revenue for 2023 was 2.2 M, a 57.01% decrease from 2022.
- Century Therapeutics, Inc. annual revenue for 2022 was 5.2 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Century Therapeutics, Inc. Market Cap — FAQ
Century Therapeutics, Inc. (IPSC) market cap over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IPSC's market cap history?
The chart and table above show Century Therapeutics, Inc.'s market cap by year and by quarter, including the growth rate.